SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-24-000025
Filing Date
2024-02-01
Accepted
2024-02-01 16:43:48
Documents
17
Period of Report
2024-02-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL bio8k2124.htm   iXBRL 8-K 25247
2 PRESS RELEASE ex99_1.htm EX-99.1 993
6 image00001.jpg GRAPHIC 1033690
7 image00002.jpg GRAPHIC 629410
  Complete submission text file 0001021771-24-000025.txt   2451541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brtx-20240201.xsd EX-101.SCH 3884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20240201_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20240201_pre.xml EX-101.PRE 16057
18 EXTRACTED XBRL INSTANCE DOCUMENT bio8k2124_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 24587575
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)